Lowell Thomas Holden - 30 Dec 2022 Form 4 Insider Report for Nascent Biotech Inc.

Role
CFO, Director
Signature
/s/ Lowell Holden
Issuer symbol
NBIO on OTC
Transactions as of
30 Dec 2022
Net transactions value
+$46,200
Form type
4
Filing time
03 Jan 2023, 14:08:58 UTC
Previous filing
25 Jul 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIO Common Stock Award $46,200 +231,000 +2.8% $0.2000* 8,398,277 30 Dec 2022 Direct
holding NBIO Common Stock 2,000,000 30 Dec 2022 Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.